Bio Impact Capital LLC Compass Therapeutics, Inc. Transaction History
Bio Impact Capital LLC
- $540 Million
- Q1 2025
A detailed history of Bio Impact Capital LLC transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 8,442,783 shares of CMPX stock, worth $26.8 Million. This represents 2.97% of its overall portfolio holdings.
Number of Shares
8,442,783
Previous 8,567,896
1.46%
Holding current value
$26.8 Million
Previous $12.4 Million
29.12%
% of portfolio
2.97%
Previous 1.86%
Shares
5 transactions
Others Institutions Holding CMPX
# of Institutions
123Shares Held
99.1MCall Options Held
2.52MPut Options Held
3.1M-
Orbimed Advisors LLC San Diego, CA22.4MShares$70.9 Million1.32% of portfolio
-
Tang Capital Management LLC San Diego, CA11.1MShares$35 Million1.36% of portfolio
-
Blackstone Inc New York, NY10MShares$31.8 Million0.09% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$21 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.96MShares$15.7 Million0.56% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $321M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...